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Ropivacaine, a safer long-acting local anesthetic
compared to bupivacaine, provides more differen-
tial block when given epidurally, allowing for a
better separation between sensory and motor
block.1 This feature can be used to its advantage
in obstetrics and in postoperative epidural pain
relief. Several reports have shown that ropivacaine-
induced severe neurotoxic side effects such as
convulsion after accidental intravenous injection
or overdose of ropivacaine and convulsive doses
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ORIGINAL ARTICLE
of ropivacaine were similar to those of bupiva-
caine.2–5 This indicated that ropivacaine-induced
convulsion was not an uncommon complication
in regional anesthesia. Local anesthetic-induced
convulsion can be handled without permanent
damage in most cases, but seizures can lead to
neuronal loss, and subsequent reorganization of
synaptic networks is well-established.6 Under-
standing the mechanism of ropivacaine-induced
neurotoxicity is beneficial to prevent the occur-
rence of ropivacaine-induced convulsion or de-
crease convulsion-induced brain damage.
With regard to the mechanisms of the local
anesthetic-induced convulsion, previous reports
indicated that γ-aminobutyric acid type A (GABAA)
receptor,7,8 N-methyl-D-aspartate (NMDA) recep-
tors and potassium channels are related.9–11 There
is still limited information about the mechanisms
underlying ropivacaine-induced neurotoxicity.
The bursts of action potentials generated from
cortical neurons of mammals are observed in ex-
perimental epilepsy studies. Pentylenetetrazole
(PTZ), which is a chemical convulsant and fre-
quently used in the study of seizure, can elicit
bursts of potential in the central neurons of snails
and these responses are strongly similar to PTZ-
induced seizure changes in the cerebral cortical
neurons of mammals.12–15 The model of bursts
of potential elicited in the snail was popularly
used in convulsant-induced seizure.16–18 Therefore,
the aim of this study was to investigate the possible
mechanisms of ropivacaine-induced neurotoxic-
ity using the central neuron of the snail. These
possible mechanisms of ropivacaine-induced
bursting in central snail neuron were tested as
follows: (1) adrenergic or cholinergic receptors;
(2) protein kinase A (PKA); (3) phospholipase C
(PLC) or protein kinase C (PKC)-related.
Methods
All animal experiments were approved by the
Animal Care Committee of National Taiwan Uni-
versity. Experiments were performed on identified
central RP4 neurons from the sub-esophageal
ganglia of the African snail, Achatina fulica Ferussac.
The ganglia were pinned to the bottom of a 2-mL
Sylgard-coated perfusion chamber and carefully
freed from the connective tissue sheath to allow
easy identification and penetration by microelec-
trodes. For intracellular recording, a Gene Clamp
500 amplifier (Axon Instruments Inc., USA) was
used. Microelectrodes (5–6 MΩ) for recording
membrane potentials were filled with 3 M KCl.
The experimental chamber was perfused with con-
trol saline, which had the following composition:
NaCl, 85 mM; KCl, 4 mM; CaCl2, 8 mM; MgCl2,
7 mM; Tris-HCl, 10 mM (pH 7.6), at room tem-
perature of 23–24°C with perfusion speed of
8 mL/min. The Ca2+-free solution was substituted
for calcium ion with equimolar amounts (8 mM)
of CoCl2.18
The resting membrane potential (RMP), ampli-
tudes of action potentials and frequency of sin-
gle spikes of action potentials of the RP4 were
recorded 60 minutes after procaine (10 mM), li-
docaine (10 mM), bupivacaine (1 mM), or ropi-
vacaine (500, 700, 900 µM) administration or
recorded at the temporary steady-state level. The
RP4 neuron was treated with 900 µM ropivacaine
for 40 minutes, and then the ropivacaine was
washed off as a pre-drug control. After the bursts
of potential elicited by ropivacaine had recov-
ered to the control level, 900 µM ropivacaine was
added for 40 minutes, then 100 µM prazosin,
100 µM propranolol, 1 mM atropine, or 100 µM
d-tubocurarine were further added for 40 min-
utes, and then washed off with normal saline for
60 minutes, firstly. Secondly, calcium-free solution
was added for 40 minutes, then 900 µM ropiva-
caine was further added for 40 minutes, and then
washed off with normal saline for 60 minutes.
Thirdly, 10 µM H89, a PKA inhibitor, was added
for 60 minutes, then 900 µM ropivacaine was
further added for 30 minutes, and then washed
off with normal saline for 60 minutes. Fourthly,
30 µM U73122, a PLC inhibitor, was added for
90 minutes, then 900 µM ropivacaine was further
added for 30 minutes, and then washed off with
normal saline for 60 minutes. On the other hand,
the RP4 neuron was treated with 3.5mM neomycin
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for 60 minutes, and then it was washed off as a
pre-drug control. After the bursts of potential
elicited by ropivacaine for 30 minutes, neomycin
was further added for 60 minutes in the presence
of 900 µM ropivacaine, and then washed off with
normal saline for 60 minutes. In addition, the RP4
neuron was treated with 30 mM high-magnesium
solution for 30 minutes, and then high-magnesium
solution was washed off as a pre-drug control. After
the bursts of potential elicited by ropivacaine for
30 minutes, high-magnesium solution was further
added for 30 minutes in the presence of 900 µM
ropivacaine, and then washed off with normal
saline for 60 minutes. In addition, 10 µM chelery-
thrine, a PKC inhibitor, was added for 60 minutes,
then 900 µM ropivacaine was further added for
30 minutes, and then washed off with normal
saline for 60 minutes. The resting membrane 
potentials, amplitudes and frequencies of single
spikes or bursts of potential were recorded in all
procedures, separately.
The ropivacaine we used in this study was a gift
from AstraZeneca (UK). Neomycin, H89, U73122
(1-[6-[((17β)-3-methoxyestra-1,3,5[10]-trien-17-
yl)amino]hexyl]-1H-pyrrole-2,5-dione), prazosin,
propranolol, atropine and d-tubocurarine were
purchased from Sigma-Aldrich Chemical Company
(St. Louis, MO, USA). Chelerythrine was pur-
chased from Tocris (Bristol, UK). All drug stocks
were made with double-distilled water except for
prazosin and U73122, which were prepared in di-
methyl sulfoxide (DMSO). The presence of DMSO
(≤ 0.1%) alone did not affect the RMP, amplitude
and frequency of the spontaneous firing of action
potentials in the RP4 neuron.
Results are expressed as mean ± standard error
of the mean. Ropivacaine and the other drugs
tested were applied by extracellular administration
and their effects were compared in the same neu-
ron. All potentials were recorded on tape by a dig-
italizing unit (Digidata 1200) (Axon Instruments
Inc., USA) and analyzed. The mean amplitude of
the potentials after various treatments was com-
pared with the pre-drug control by means of
Student’s two-tailed t test. Differences were con-
sidered significant at p < 0.05.
Results
Identifiable RP4 neuron of Achatina 
fulica Ferussac
The RMP of the identified RP4 neuron was –58.0±
1.5 mV (n = 3), and the frequency of single spikes
was about 35.3 ± 3.9 pulses/min. The mean am-
plitude of the spontaneously generated action
potentials was 96.8 ± 1.3 mV (Table). The neuron
was sensitive to several neurotransmitters, such
as acetylcholine, GABA, glutamic acid, dopamine
and serotonin.
Effects of procaine, lidocaine, bupivacaine, 
or ropivacaine on the RP4 neuron
The effects of various concentrations of ropiva-
caine (500, 700, 900 µM) on the RP4 neuron are
shown in Figure 1. Ropivacaine did not alter the
RMP and amplitude of action potential of the RP4
neuron at all of the concentrations tested, but
ropivacaine decreased the frequency of sponta-
neous firing action potential. Sixty minutes after
500 µM ropivacaine administration, the frequency
of the spontaneous firing of action potentials de-
creased from 35.3 ± 3.9 pulses/min (control) to
31.5 ± 1.5 pulses/min. Sixty minutes after 700 µM
ropivacaine administration, the frequency of 
the spontaneous firing of action potentials de-
creased to 26.0 ± 0.1 pulses/min. Increasing ropi-
vacaine concentration to 900 µM elicited a phasic
depolarization and hyperpolarization phase as
well as a steady state level of RMP on the RP4 neu-
ron during bursts of potential. A dose of 900 µM
ropivacaine elicited bursts of potential 30 minutes
after ropivacaine administration, and the bursts
of potential lasted for more than 60 minutes.
The frequency of bursts was 7.0 ± 1.0 bursts/min
(Table). The bursts of potential elicited by ropi-
vacaine had recovered to control levels after 60
minutes of continuous washing with normal
saline. It appeared that a higher concentration of
ropivacaine (900 µM) reversibly elicited bursts of
potential in the RP4 neuron.
The effects of procaine, lidocaine, bupivacaine,
and ropivacaine on RP4 neurons are shown in
Figure 2. Sixty minutes after 10 mM procaine 
Ropivacaine-induced neurotoxicity
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Table. Effect of ropivacaine on the resting membrane potential (RMP), amplitude and frequency of spontaneously generated
action potentials of the RP4 neuron and the effects of H89, U73122, neomycin, calcium-free solution and high-magnesium
solution on ropivacaine-elicited changes in the RP4 neuron
RMP (mV) Amplitude (mV)
Frequency of single Frequency of bursts
spikes (pulses/min) (bursts/min)
Ropivacaine (n = 3)
Control −58.0 ± 1.5 96.8 ± 1.3 35.3 ± 3.9 –
500 µM −56.5 ± 1.5 93.6 ± 0.8 31.5 ± 1.5 –
700 µM −56.0 ± 1.0 94.3 ± 3.1 26.0 ± 0.1 –
900 µM −62.5 ± 1.5 98.1 ± 3.0 – 7.0 ± 1.0
H89 (n = 3)
Control −56.5 ± 3.5 94.9 ± 1.1 36.0 ± 6.0 –
+ ropivacaine 900 µM −59.0 ± 3.0 95.4 ± 2.4 – 5.5 ± 0.5
U73122 (n = 3)
Control −58.5 ± 1.5 87.9 ± 1.6 33.0 ± 3.0 –
+ ropivacaine 900 µM −61.0 ± 4.5 89.1 ± 3.1 28.5 ± 6.0 –
Neomycin (n = 3)
Control −59.5 ± 1.5 97.5 ± 1.5 33.0 ± 3.0 –
+ ropivacaine 900 µM −48.0 ± 7.0* 84.9 ± 3.9* 28.7 ± 1.7 –
Ca2+ free (n = 3)
Control −60.4 ± 1.4 93.8 ± 2.1 37.7 ± 0.9 –
+ ropivacaine 900 µM −52.0 ± 2.0* 61.0 ± 3.7* – 7.3 ± 0.7
High Mg2+ (n = 3)
Control −60.5 ± 0.5 96.0 ± 0.1 42.0 ± 3.0 –
+ ropivacaine 900 µM −58.5 ± 1.0 93.8 ± 1.8 25.5 ± 1.5* –
*Statistically significant compared with the data in physiologic solution (control), p < 0.05.
Control
500 µM
700 µM
900 µM
A 30 min 60 min Wash
ControlB 30 min 60 min Wash
ControlC 30 min 60 min Wash
60 mV
10 sec
Figure 1. Effects of ropivacaine on the central RP4 neuron of the African snail Achatina fulica Ferussac. Control in A, B,
C were potentials of control in the RP4 neurons. At 30 and 60 minutes in A, B, C were potentials after 30 and 60 min-
utes of ropivacaine (500, 700, 900 µM) application, respectively. At washing 60 minutes in A, B, C were potentials after
60 minutes of washing off with normal saline from preparations incubated for 60 minutes with ropivacaine of A–C, 
respectively. The horizontal bar at the top left indicates the membrane potential at 0 mV.
administration, it elicited bursts of potential.
Lidocaine also elicited bursts of potential 60
minutes after 10 mM lidocaine administration.
Bupivacaine elicited bursts of potential 30 min-
utes after 1 mM bupivacaine treatment.
Effects of adrenergic and cholinergic blocking
agents on ropivacaine-elicited bursting
activity of the RP4 neuron
Bursts of potential elicited by 900 µM ropivacaine
were not altered after 40 minutes of incubation
with 100 µM prazosin, 100 µM propranolol, 1 mM
atropine, and 100 µM d-tubocurarine (Figure 3).
Effects of calcium-free solution on ropivacaine-
elicited bursting activity of the RP4 neuron
At 20 minutes after incubation with Ca2+-free so-
lution, Ca2+-free solution did not alter the RMP,
amplitudes and frequency of action potentials of
the RP4 neuron. Compared with neurons treated
with Ca2+-free solution, the RMP and amplitude
of action potential in the RP4 neurons were 
decreased in 900 µM ropivacaine and Ca2+-free
solution treated preparations (p < 0.05) (Table).
Bursts of potential were found in Ca2+-free solu-
tion and ropivacaine-treated preparations. Ropi-
vacaine (900 µM) still elicited bursts of potential
in preparations pretreated with Ca2+-free solution
(Figure 4).
Effects of PKA inhibitor on ropivacaine-
elicited bursting activity of the RP4 neuron
A dose of 10 µM H89 did not alter the RMP, am-
plitudes and frequency of spontaneous action
potentials of the RP4 neuron (Table), while 900µM
ropivacaine still elicited bursts of potential in
preparations pretreated with 10µM H89 (Figure 5).
Effects of PLC inhibitors on ropivacaine-
elicited bursting activity of the RP4 neuron
To examine whether PLC was involved in the gen-
eration of burst firing of the frequency of sponta-
neously generated action potentials of the RP4
neuron, the effects of U73122 and neomycin, in-
hibitors of PLC, on the ropivacaine-elicited bursts
of potential were tested.
Ropivacaine-induced neurotoxicity
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2
30 min
3
60 min
4
Wash
30 min 60 min Wash
10 min 30 min Wash
10 min 30 min Wash
1
ControlA
ControlB
ControlC
ControlD
60 mV
10 sec
Procaine
10 mM
Lidocaine
10 mM
Bupivacaine
1 mM
Ropivacaine
900 µM
Figure 2. Effects of 10 mM procaine, 10 mM lidocaine, 1 mM bupivacaine, and 900 µM ropivacaine on the RP4 neuron
of the African snail Achatina fulica Ferussac. A1, B1, C1 and D1 were controls, showing spontaneous firing of action po-
tentials. A2 and A3 were potentials 30 and 60 minutes after the application of 10 mM procaine, respectively. B2 and B3
were potentials 30 and 60 minutes after application of 10 mM lidocaine, respectively. C2 and C3 were potentials 10 and
30 minutes after application of 1 mM bupivacaine, respectively. D2 and D3 were potentials 10 and 30 minutes after 
application of 900 µM ropivacaine, respectively. A4, B4, C4 and D4 were 60 minutes after washing off with normal 
physiologic solution. The horizontal bar at the top left indicates the membrane potential at 0 mV.
A dose of 30µM U73122 did not alter the RMP,
amplitude and frequency of the action potential
of the RP4 neuron (Table). No bursts of potential
were found in the 30 µM U73122- and 900 µM
ropivacaine-treated preparations tested (Figure 6).
It appeared that U73122 significantly abolished
the bursts of potential elicited by ropivacaine.
At 60 minutes after incubation with 3.5 mM
neomycin, neomycin did not alter the RMP, am-
plitudes and frequency of spontaneous action
potentials of the RP4 neuron (Table). Compared
with the neurons treated with 3.5 mM neomycin,
the RMP and amplitude of the spontaneously gen-
erated action potentials of the RP4 neuron were
decreased in 900 µM ropivacaine- and 3.5 mM
neomycin-treated preparations (p < 0.05). No
bursts of potential were found in the 3.5 mM
neomycin- and 900 µM ropivacaine-treated prepa-
rations tested (Figure 7), indicating that neomycin
significantly altered the bursts of potential elicited
by ropivacaine.
Effects of high-magnesium solution on
ropivacaine-elicited bursting activity 
of the RP4 neuron
The effects of 30 mM high-magnesium solution
on 900 µM ropivacaine-elicited changes in RMP,
amplitude of action potential, and frequency of
action potential in the RP4 neuron are shown in
the Table. High-magnesium solution 30 mM did
not alter the RMP, amplitude and frequency of
the action potential of the RP4 neuron.
P.L. Lin, et al
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Ropivacaine (900 µM)
40 min
3
Propranolol (100 µM)
+ ropivacaine (900 µM)
40 min WashControl
Ropivacaine (900 µM)
40 min
Prazosin (100 µM)
+ ropivacaine (900 µM)
40 min Wash
Ropivacaine (900 µM)
40 min
d-tubocurarine (100 µM)
+ ropivacaine (900 µM)
40 min Wash
Ropivacaine (900 µM)
40 min
Atropine (1 mM)
+ ropivacaine (900 µM)
40 min Wash
A
Control
B
Control
C
Control
D
2 41
60 mV
10 sec
Figure 3. Effects of prazosin, propranolol, d-tubocurarine and atropine on ropivacaine-elicited bursts of potential. A1,
B1, C1 and D1 were controls, showing spontaneous firing of action potentials. A2, B2, C2 and D2 were potentials after
addition of 900 µM ropivacaine for 40 minutes. A3, B3, C3 and D3 were potentials after addition of 100 µM prazosin,
100 µM propranolol, 100 µM d-tubocurarine and 1 mM atropine for 40 minutes from A2, B2, C2 and D2, respectively.
A4, B4, C4 and D4 were 60 minutes after washing off with normal physiologic solution from A3, B3, C3 and D3, respec-
tively. The horizontal bar at the top left indicates the membrane potential at 0 mV.
Compared with the neurons treated with
30 mM high-magnesium solution, the RMP and
amplitudes of action potentials of the neuron
were not altered, whereas it decreased the fre-
quency of spontaneous action potentials of the
RP4 neuron in 900 µM ropivacaine- and 30 mM
high-magnesium solution-treated preparations
(p < 0.05). No bursts of potential were found in
the high-magnesium solution- and ropivacaine-
treated preparations tested (Figure 8).
Ropivacaine-induced neurotoxicity
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Control Ropivacaine (900 µM) 40 min
Ca2+-free solution 20 min
Ca2+-free + ropivacaine (900 µM) 40 min
Wash
Wash
A B
C D
E F
60 mV
10 sec
Figure 4. Continuous recording showing the effects of calcium ion on ropivacaine-elicited bursts of potential on the central
RP4 neuron of the African snail Achatina fulica Ferussac (data are from the same neuron). (A) Control shows spontaneous
firing of action potentials. (B) 40 minutes after application of 900 µM ropivacaine. (C) 60 minutes after washing the
preparation from B with normal physiologic solution. (D) 20 minutes after perfusion with the calcium-free solution from
C. (E) 60 minutes after the addition of 900 µM ropivacaine to the preparation from D. (F) 60 minutes after washing the
preparation from E with normal physiologic solution. The horizontal bar at the top left indicates the membrane potential
at 0 mV.
Control Ropivacaine (900 µM) 30 min
H89 (10 µM) + ropivacaine (900 µM) 30 min
H89 (10 µM) 60 minWash
Wash
A B
C D
E F
60 mV
10 sec
Figure 5. Continuous recording showing the effects of 10 µM H89 on ropivacaine-elicited bursts of potential on the cen-
tral RP4 neuron of the African snail Achatina fulica Ferussac (data are from the same neuron). (A) Control shows spon-
taneous firing of action potentials. (B) 30 minutes after application of 900 µM ropivacaine. (C) 60 minutes after washing
the preparation from B with normal physiologic solution. (D) 60 minutes after application of 10 µM H89. (E) 30 minutes
after the addition of 900 µM ropivacaine to the preparation from D. (F) 60 minutes after washing the preparation from E
with normal physiologic solution. The horizontal bar at the top left indicates the membrane potential at 0 mV.
Effects of PKC inhibitor on ropivacaine-
elicited bursting activity of the RP4 neuron
A does of 10 µM chelerythrine did not alter the
RMP, amplitudes and frequency of spontaneous
action potential of the RP4 neuron, while
900 µM ropivacaine still elicited bursts of po-
tential in preparations pretreated with 10 µM
chelerythrine.
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Control Ropivacaine (900 µM) 30 min
U73122 (30 µM) + ropivacaine
(900 µM) 30 min
U73122 (30 µM) 90 minWash
Wash
A B
C D
E
F
60 mV
10 sec
Figure 6. Continuous recording showing the effects of 30 µM U73122 on ropivacaine-elicited bursts of potential on the
central RP4 neuron of the African snail Achatina fulica Ferussac (data are from the same neuron). (A) Control shows spon-
taneous firing of action potentials. (B) 30 minutes after application of 900 µM ropivacaine. (C) 60 minutes after washing
the preparation from B with normal physiologic solution. (D) 90 minutes after application of 30 µM U73122. (E) 30 min-
utes after the addition of 900 µM ropivacaine to the preparation from D. (F) 60 minutes after washing the preparation
from E with normal physiologic solution. The horizontal bar at the top left indicates the membrane potential at 0 mV.
Control Neomycin (3.5 mM) 60 min
Neomycin (3.5 mM) + ropivacaine
(900 µM) 60 min
Ropivacaine (900 µM) 30 minWash
Wash
A B
C D
E
F
60 mV
10 sec
Figure 7. Effects of 3.5 mM neomycin on ropivacaine-elicited bursts of potential. (A) Control shows spontaneous firing
of action potentials. (B) 60 minutes after a further addition of 3.5 mM neomycin. (C) 60 minutes after washing the prepa-
ration from B with normal physiologic solution. (D) 30 minutes after application of 900 µM ropivacaine. (E) 60 minutes
after addition of 3.5 mM neomycin in the presence of 900 µM ropivacaine. (F) 60 minutes after washing the preparation
from E with normal physiologic solution. The horizontal bar at the top left indicates the membrane potential at 0 mV.
Discussion
The current study showed that ropivacaine-elicited
bursts of potential were not directly related to
adrenergic receptor, cholinergic receptor, extra-
cellular calcium ion fluxes, PKA or PKC activity,
but strongly associated with PLC activity in the RP4
snail neuron. This is the first study to address the
second messenger regarding the possible mecha-
nism of ropivacaine-elicited bursts of potential.
It has been shown that local anesthetic-induced
seizure discharge may emanate mainly from the
amygdala and hippocampus in the limbic sys-
tem.19 With regard to in vivo model of seizure, it
is difficult to investigate the mechanism of con-
vulsion from the specific neurons or synapses
because of the numerous neurons and glial cells
involved while the convulsant agent is injected
into the animal. As to in vitro study from brain
slice, it would take much time to prepare and
preincubate. In addition, these neurons showed
high sensitivity for applied agents and unstable
environment. Therefore, it is too difficult to make
a serial pharmacologic study in one specific neu-
ron. In contrast, it is easy to isolate an identified
neuron for intracellular recordings and make a
serial pharmacologic study in one specific central
neuron of the snail. Almost all of the mammalian
small molecule neurotransmitters were effective in
the snail.20 Snails, which have been shown to have
many similarities in their central neuron com-
pared to mammals, can help us make a prelimi-
nary report that is not yet feasible in mammalian
systems.
In general, central nervous system toxicity is
proportional to local anesthetic potency of various
drugs. According to the timing of the appearance
of bursts of potential, these data are in agreement
with previously reported ranking order of local
anesthetic-induced toxicity as follows: procaine
< lidocaine < ropivacaine = bupivacaine.5,21
It has been reported that both cholinergic and
adrenergic mechanisms play important roles in
the initiation and termination of limbic seizure
and acute excitement and seizure caused by in-
troduction of neuromuscular blocking drug.22,23
But the ropivacaine-elicited bursts of potential
were not altered after perfusion with prazosin,
propranolol, atropine and d-tubocurarine. These
results suggest that ropivacaine-elicited bursts of
Ropivacaine-induced neurotoxicity
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Control High Mg2+ (30 mM) 30 min
High Mg2+ (30 mM) + ropivacaine
(900 µM) 30 min
Ropivacaine (900 µM) 30 minWash
Wash
A B
C D
E
F
60 mV
10 sec
Figure 8. Effects of high-Mg2+ solution on ropivacaine-elicited bursts of potential. (A) Control shows spontaneous firing
of action potentials. (B) 30 minutes after a further addition of 30 mM high-Mg2+. (C) 60 minutes after washing the prepa-
ration from B with normal physiologic solution. (D) 30 minutes after application of 900µM ropivacaine. (E) 60 minutes after
addition of 30 mM high-Mg2+ in the presence of 900 µM ropivacaine. (F) 60 minutes after washing the preparation from
E with normal physiologic solution. The horizontal bar at the top left indicates the membrane potential at 0 mV.
potential are not directly related to cholinergic
or adrenergic receptors.
However, cytosolic free Ca2+ concentration is
a key factor to control a wide range of cellular
functions in excitable and non-excitable cells.
Ca2+ release from intracellular stores and the
subsequent activation of Ca2+ entry from the ex-
tracellular medium contribute to the cytosolic
free Ca2+ concentration.24 The neurons perfused
with calcium-free solution resulted in the elimi-
nation of extracellular calcium influx and the 
interference of neurotransmitter release.25 The
ropivacaine-elicited bursts of potential remained
unchanged in calcium-free solution. It indicated
that calcium influx and neurotransmitters were
also not directly related to ropivacaine-elicited
bursts of potential.
Onozuka and co-workers have shown that
PTZ-elicited bursting activity is involved in cyclic
AMP-dependent protein phosphorylation.15 Pre-
treatment with H89, a PKA inhibitor,26 cannot
block the ropivacaine-elicited bursts of potential.
It appears that PKA activity is not associated with
the ropivacaine-elicited bursts of potential.
As to the relationship between ropivacaine and
PLC activity, some evidence should be explained.
Dubeau et al reported that phosphoinositide
(PI) turnover was significantly reduced in active
epileptic cortex compared to inactive cortex, sug-
gesting a PI cycle uncoupling that would prevent
modulation of neuronal activity.27 First, U73122,
which inhibits phosphatidylinositol and phos-
phatidylinositol 4-phosphate kinases and affects
PLC activity,28 can block the bursts of potential
elicited by ropivacaine. Second, neomycin, a poly-
cationic aminoglycoside antibiotic, can bind with
high affinity phosphatidylinositol-4,5-diphosphate
(PIP2).29 Blockade of ropivacaine-elicited bursts
of potential by neomycin was observed. Third,
magnesium ions can act at many steps of the 
G-protein cycle and PI metabolism. Magnesium
sulfate appeared to inhibit PIP2-specific PLC ac-
tivity and subsequent calcium release in cultured
myometrial cells.30 Ropivacaine-elicited bursts of
potential were also blocked by application of
high-magnesium solution. Taken together, these
findings suggest that ropivacaine-elicited bursts of
potential were strongly associated with PLC activ-
ity, and PLC activity may influence the occurrence
of ropivacaine-induced neurotoxicity.
In the classical model of PKC activation, the
first step in the cascade is the activation of PLC via
G protein-linked receptors. Activated PLC cleaves
PIP2 to generate two second messengers, diacyl-
glycerol (DAG) and inositol-1,4,5-trisphosphate
(IP3). Signaling via the IP3/DAG pathway leads to
an increase in cytosolic Ca2+ and to activation of
PKC. PKC is a signal transducing enzyme that is
an important regulator of multiple physiologic
processes like neurotransmitter release, ion chan-
nel activity, and neurotransmitter receptor desen-
sitization.31 PKC is a possible molecular target for
the synaptic action of anesthetics. Chelerythrine
is commonly used as a PKC inhibitor.32 The pat-
tern of ropivacaine-elicited bursts of potential was
not altered after chelerythrine treatment. It would
appear that PKC activity is not associated with
the ropivacaine-elicited bursts of potential.
These data can provide benefits for further in-
vestigation in the hippocampus or other synapses
in the mammalian brain. Particularly, ropivacaine
has a similar structure to other amide local anes-
thetics. Ropivacaine and bupivacaine are produced
when the methyl group (-CH3), situated on the ni-
trogen ion of mepivacaine, is replaced by a propyl
group (-C3H7) in ropivacaine and by a butyl group
(-C4H9) in bupivacaine. Therefore, these findings
imply that the mechanism involved in other amide
local anesthetic-induced neurotoxicity may cor-
relate closely with PLC activity.
In summary, ropivacaine reversibly elicited
bursts of potential on the RP4 neuron of the
African snail Achatina fulica Ferussac. We suggest
that ropivacaine-elicited bursts of potential are
closely associated with PLC activity, and not 
directly related to: (1) cholinergic or adrenergic
receptors; (2) extracellular calcium ion fluxes; or
(3) PKA and PKC activity in the neuron. In this
manner, the results of the study suggest that
ropivacaine-induced neurotoxicity may be de-
pendent on PLC activity, and PLC inhibitor may
be a possible strategy to manage and prevent the
P.L. Lin, et al
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occurrence of local anesthetic-induced convulsion
or other transient neurologic toxicity.
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